-
,for, Item ID-
- #1184105
- Covidien #8886614921-2
Absorbable Suture with Needle Maxon™ Polyglyconate CV-22 1/2 Circle Taper Point Needle Size 5-0 Monofilament
SUTURE, MAXON CV GRN 5-0 30" CV-23 DA (36/PK)
No Image
Features
- MAXON™ and MAXON™ CV synthetic absorbable sutures are prepared from polyglyconate, a copolymer of glycolic acid and trimethylene carbonate
- MAXON™ and MAXON™ CV synthetic absorbable sutures are indicated for use in general soft tissue approximation and/or ligation, including use in pediatric cardiovascular tissue, where growth is expected to occur, and in peripheral vascular surgery
- MAXON™ and MAXON™ CV synthetic absorbable sutures are not indicated for use in adult cardiovascular tissue, ophthalmic surgery, microsurgery and neural tissues
- More …
Product Details Email
Product Specifications
McKesson # | 1184105 |
---|---|
Manufacturer # | 8886614921-2 |
Brand | Maxon™ |
Manufacturer | Covidien |
Country of Origin | Unknown |
Application | Absorbable Suture with Needle |
Coating | Uncoated |
Needle 1 Code | CV-22 |
Needle 2 Code | CV-22 |
Needle Length | 13 mm |
Needle Length Range | 10.1 to 20 mm |
Needle Material | Surgalloy Needle |
Needle Shape | 1/2 Circle |
Needle Type | Taper Point Needle |
Number of Needles | Double-Armed |
Sterility | Sterile |
Suture Color | Green |
Suture Length | 30 Inch Suture |
Suture Length Range | 20.1 to 40 in |
Suture Material | Polyglyconate |
Suture Material Range | Dyed Synthetic |
Suture Size | Size 5-0 |
Suture Type | Monofilament |
UNSPSC Code | 42312201 |
Features
- MAXON™ and MAXON™ CV synthetic absorbable sutures are prepared from polyglyconate, a copolymer of glycolic acid and trimethylene carbonate
- MAXON™ and MAXON™ CV synthetic absorbable sutures are indicated for use in general soft tissue approximation and/or ligation, including use in pediatric cardiovascular tissue, where growth is expected to occur, and in peripheral vascular surgery
- MAXON™ and MAXON™ CV synthetic absorbable sutures are not indicated for use in adult cardiovascular tissue, ophthalmic surgery, microsurgery and neural tissues
- MAXON™ sutures retain approximately 75% of initial tensile strength at two weeks, 65% of at three weeks and 50% at four weeks post-implant
- Absorption of MAXON™ sutures is minimal until about 60 days after implant and is essentially complete within six months
More Information
Frequently Viewed Together
-
,for, Item ID-
- #501218
- Covidien #SMM-5526
-
,for, Item ID-
- #1154494
- J & J Healthcare Systems #Z316H
-
,for, Item ID-
- #504615
- Covidien #SMM-5536
-
,for, Item ID-
- #171664
- Covidien #8886661231
-
,for, Item ID-
- #139966
- J & J Healthcare Systems #Z303H
-
,for, Item ID-
- #171686
- Covidien #8886661241
-
,for, Item ID-
- #129271
- J & J Healthcare Systems #Z304H
-
,for, Item ID-
- #171445
- Covidien #8886661851
-
,for, Item ID-
- #564189
- Covidien #8886660841
-
,for, Item ID-
- #129272
- J & J Healthcare Systems #Z305H
-
,for, Item ID-
- #506676
- Covidien #SMM-5044
-
,for, Item ID-
- #171444
- Covidien #8886661841
-
,for, Item ID-
- #182439
- J & J Healthcare Systems #Z320H
-
,for, Item ID-
- #129816
- J & J Healthcare Systems #Z359T
-
,for, Item ID-
- #185435
- J & J Healthcare Systems #Z148H
-
,for, Item ID-
- #166661
- Covidien #8886626751